ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

Two Sarcoma Drugs Pose Classic Question: How Much PFS Does it Take to Get a Nod?

March 30, 2012

Sen. Arlen Specter Remembered as Champion Of Federal Biomedical Resesarch Funding

October 19, 2012

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976